| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2010 , Vol 52 , Num 4
DESIGN AND OPTIMIZATION OF MUCOADHESIVE HYDROPHILIC MATRIX TABLET CONTAINING ATENOLOL USING CENTRAL COMPOSITE DESIGN
Unison Pharmaceuticals Limited, Ahmedabad, Gujarat, India
Viewed :
18067
-
Downloaded :
5755
The current study involves development of oral mucoadhesive hydrophilic matrices of atenolol, and optimization of their in vitro drug release profile and ex vivo mucoadhesion against goat intestinal mucosa. A 32 central composite design (CCD) was employed to systematically optimize the drug delivery formulations containing two polymers, viz., chitosan-652 and hydroxypropyl methylcellulose K100MCR (HPMC K100MCR). Response surface plots and contour plots were drawn, and optimum formulations were selected by feasibility and grid searches. Both the polymers had significant effect on the mucoadhesive strength of the tablets, measured as force of detachment against goat intestinal mucosa. Validation of the formulation optimization study carried out using six confirmatory runs, indicated a very high degree of prognostic ability. The study successfully undertook the development of an optimized once-a-day formulation of atenolol with excellent mucoadhesive and controlled release characteristics.
Keywords :
ATENOLOL, EXPERIMENTAL DESIGN, MUCOADHESIVE, RESPONSE SURFACE METHODOLOGY, CENTRAL COMPOSITE DESIGN